A detailed history of Impact Investors, Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Impact Investors, Inc holds 6,100 shares of NVO stock, worth $295,606. This represents 0.22% of its overall portfolio holdings.

Number of Shares
6,100
Previous 9,327 34.6%
Holding current value
$295,606
Previous $644 Million 47.42%
% of portfolio
0.22%
Previous 0.45%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 29, 2025

SELL
$45.38 - $71.7 $146,441 - $231,375
-3,227 Reduced 34.6%
6,100 $338 Million
Q2 2025

Jul 21, 2025

BUY
$58.08 - $81.05 $210,772 - $294,130
3,629 Added 63.69%
9,327 $644 Million
Q1 2025

Apr 25, 2025

BUY
$69.3 - $90.95 $48,787 - $64,028
704 Added 14.1%
5,698 $396 Million
Q4 2024

Feb 04, 2025

BUY
$85.0 - $120.04 $424,490 - $599,479
4,994 New
4,994 $430 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $109B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Impact Investors, Inc Portfolio

Follow Impact Investors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Impact Investors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Impact Investors, Inc with notifications on news.